Ritonavir Unknown Status Phase 0 Trials for Pulmonary Arterial Hypertension (PAH) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT02023450Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension